[123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes
- PMID: 18397978
- DOI: 10.1210/jc.2008-0050
[123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes
Abstract
Background: Due to advances in conventional imaging, adrenal tumors are detected with increasing frequency. However, conventional imaging provides only limited information on the origin of these lesions, which represent a wide range of different pathological entities. New specific imaging methods would therefore be of great clinical value. We, therefore, studied the potential of iodometomidate (IMTO) as tracer for molecular imaging of cytochrome P450 family 11B (Cyp11B) enzymes.
Methods: Inhibition of Cyp11B1 and Cyp11B2 by IMTO, etomidate, metomidate, and fluoroetomidate was investigated in NCI-h295 cells and in Y1 cells stably expressing hsCyp11B1 or hsCyp11B2. Pharmacokinetics and biodistribution after iv injection of [(123/125)I]IMTO were analyzed in mice in biodistribution experiments and by small-animal single-photon emission computed tomography (SPECT). Furthermore, four patients with known adrenal tumors (two metastatic adrenal adenocarcinomas, one bilateral adrenocortical adenoma, and one melanoma metastasis) were investigated with [(123)I]iodometomidate-SPECT.
Results: In cell culture experiments, all compounds potently inhibited both Cyp11B1 and Cyp11B2. Adrenals showed high and specific uptake of [(123/125)I]IMTO and were excellently visualized in mice. In patients, adrenocortical tissue showed high and specific tracer uptake in both primary tumor and metastases with short investigation time and low radiation exposure, whereas the non-adrenocortical tumor did not exhibit any tracer uptake.
Conclusion: We have successfully completed the development of an in vivo detection system of adrenal Cyp11B enzymes by [(123)I]IMTO scintigraphy in both experimental animals and humans. Our findings suggest that [(123)I]IMTO is a highly specific radiotracer for imaging of adrenocortical tissue. Due to the general availability of SPECT technology, we anticipate that [(123)I]IMTO scintigraphy may become a widely used tool to characterize adrenal lesions.
Similar articles
-
Functional characterization of adrenal lesions using [123I]IMTO-SPECT/CT.J Clin Endocrinol Metab. 2013 Apr;98(4):1508-18. doi: 10.1210/jc.2012-3045. Epub 2013 Feb 20. J Clin Endocrinol Metab. 2013. PMID: 23426614
-
[¹²³I]Iodometomidate imaging in adrenocortical carcinoma.J Clin Endocrinol Metab. 2013 Jul;98(7):2755-64. doi: 10.1210/jc.2012-3261. Epub 2013 Apr 22. J Clin Endocrinol Metab. 2013. PMID: 23609836
-
Metomidate-based imaging of adrenal masses.Horm Cancer. 2011 Dec;2(6):348-53. doi: 10.1007/s12672-011-0093-3. Horm Cancer. 2011. PMID: 22124841 Free PMC article. Review.
-
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience.Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):301-310. doi: 10.1007/s00259-021-05477-y. Epub 2021 Jul 3. Eur J Nucl Med Mol Imaging. 2021. PMID: 34215922 Free PMC article.
-
[Molecular basics of aldosterone and cortisol synthesis in normal adrenals and adrenocortical adenomas].Endokrynol Pol. 2008 Jul-Aug;59(4):330-9. Endokrynol Pol. 2008. PMID: 18777504 Review. Polish.
Cited by
-
Clinical and molecular pharmacology of etomidate.Anesthesiology. 2011 Mar;114(3):695-707. doi: 10.1097/ALN.0b013e3181ff72b5. Anesthesiology. 2011. PMID: 21263301 Free PMC article. Review.
-
Radiopharmaceuticals for Treatment of Adrenocortical Carcinoma.Pharmaceuticals (Basel). 2023 Dec 23;17(1):25. doi: 10.3390/ph17010025. Pharmaceuticals (Basel). 2023. PMID: 38256859 Free PMC article. Review.
-
Advances in the molecular imaging of primary aldosteronism.Ann Nucl Med. 2023 Aug;37(8):433-441. doi: 10.1007/s12149-023-01851-y. Epub 2023 Jul 2. Ann Nucl Med. 2023. PMID: 37393373 Review.
-
Adrenocortical carcinoma: modern management and evolving treatment strategies.Int J Endocr Oncol. 2016 May;3(2):161-174. doi: 10.2217/ije-2015-0003. Epub 2016 Apr 8. Int J Endocr Oncol. 2016. PMID: 27213037 Free PMC article.
-
Targeted Molecular Imaging in Adrenal Disease-An Emerging Role for Metomidate PET-CT.Diagnostics (Basel). 2016 Nov 18;6(4):42. doi: 10.3390/diagnostics6040042. Diagnostics (Basel). 2016. PMID: 27869719 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials